Pharmaceutical manufacturing at scale requires flexibility, cGMP compliance and advanced technology to ensure safe, reliable medications for patients.
Delivering Billions of Doses for the Patients who Depend Upon Them
Pharmaceutical Manufacturing With the Patient in Mind
Every dose of medication represents a patient who depends on it being available, safe and effective when they need it most. Ensuring that reliability requires pharmaceutical manufacturers that can produce medicines at scale while maintaining the highest standards of quality.
With an annual output of up to 2.6 billion unit doses, Ritedose is the leading Blow-Fill-Seal producer of respiratory and ophthalmic medications in the U.S. Since 2012, more than 14 billion doses have been manufactured at our Columbia facility and delivered to patients around the world.
That scale comes with significant responsibility. At Ritedose, our manufacturing processes are designed to ensure every dose meets the same uncompromising standards of quality and safety. It’s why we remain committed to getting it “right the first time, every time.”
Why cGMP Matters for Patients
For patients, every medication comes with an expectation: that it will be safe, effective and consistent every time it is used. Delivering on that expectation begins long before a medicine reaches a hospital, clinic or pharmacy. It starts in the manufacturing facility, where strict standards govern how drugs are produced, tested and released.
Those standards are known as Current Good Manufacturing Practice (cGMP). These regulations establish the framework pharmaceutical manufacturers must follow to ensure medicines are consistently produced and controlled according to quality standards.
For patients, cGMP requirements translate directly into protections that safeguard the medicines they depend on. Patients rely on medications that work the same way every time they are used, consistency from dose to dose. cGMP standards ensure that each batch of a drug contains the correct ingredients, in the correct amounts and performs as intended.
Sterile medicines, such as those produced using Blow-Fill-Seal technology, must be manufactured in highly controlled environments. cGMP regulations require rigorous environmental monitoring, validated sterilization processes, and strict controls that reduce the risk of contamination.
Every step in pharmaceutical manufacturing is documented under cGMP standards. From raw material sourcing to final product release, manufacturers maintain detailed records that allow every batch to be traced and verified. If an issue ever arises, these systems enable rapid investigation and corrective action to protect patients.
Most importantly, cGMP ensures that quality cannot change even when production levels must. When demand for critical medications increases, manufacturers must respond without compromising the safeguards that protect patients.
That discipline guides every aspect of our operations. At Ritedose, operational flexibility comes from carefully designed processes that allow teams to adjust production while maintaining full compliance.
A Commitment to Quality
At Ritedose, these standards guide every aspect of operations. Whether manufacturing output is steady or increasing to respond to supply needs, the same rigorous controls remain in place to ensure every unit produced meets the expectations of healthcare providers, regulators and the patients who depend on these medications.
How cGMP Manufacturing Enables Output
Adjusting manufacturing output is not as simple as increasing the speed of a production line. In pharmaceutical manufacturing, every change must occur within the strict framework of cGMP requirements, which ensure medicines are consistently produced and controlled according to quality standards.
At Ritedose, the use of multiple Blow-Fill-Seal (BFS) lines allows operations teams to redistribute manufacturing capacity while maintaining strict cGMP compliance.
The Pharmaceutical Manufacturing Process
Drug production begins by confirming that all necessary materials are available and cleared for use. The components used in manufacturing are carefully vetted and sourced from trusted suppliers to ensure consistent quality.
When materials arrive at the facility, they are placed in quarantine and undergo rigorous quality control testing to verify they meet strict specifications before entering production.
Once approved, the materials move into the manufacturing process, beginning with the precise weighing and kitting of components for each batch. This step ensures the correct quantities of ingredients are allocated to specific drug lots, supporting complete traceability throughout production. Manufacturing data is tracked through Epicor, the enterprise resource planning system used to coordinate manufacturing, supply chain and distribution.
Formulation begins once materials are prepared. During this stage, active pharmaceutical ingredients (API) are combined with inactive ingredients or excipients to create a safe, stable and effective formulation.
At Ritedose, formulation occurs in ISO-8 cleanrooms designed to limit airborne particulates and protect product quality. Water used in the process undergoes a six-stage distillation process to ensure the highest levels of purity. Throughout formulation, samples are collected and analyzed to verify that each batch meets strict quality standards.
Once formulation is complete, the drug product is transferred into sterilized mobile tanks connected to Blow-Fill-Seal (BFS) machines for filling.
BFS technology integrates container formation, filling and sealing into a single automated process. This allows sterile products to be manufactured efficiently while maintaining strict environmental control. This integrated manufacturing process also enables the high-volume production of sterile unit-dose medications, making BFS particularly well suited for respiratory and ophthalmic therapies.
Throughout filling, additional samples are collected and analyzed to ensure the product meets established quality specifications.
By leveraging multiple BFS lines and validated production transfers, Ritedose can adjust manufacturing output when demand changes while maintaining the consistency required in sterile pharmaceutical production.
Quality teams remain closely involved throughout the process. Environmental monitoring, equipment verification and in-process testing continue as production increases to ensure every unit produced meets established standards.
Meeting production demands requires careful planning. Each manufacturing line must be properly validated and qualified to produce specific drug products. Through coordinated oversight, Ritedose quality teams ensure all documentation, environmental controls and production parameters remain fully compliant throughout the process.
These safeguards ensure that increasing output never comes at the expense of product quality or patient safety.
Why Manufacturing Flexibility Matters
In today’s healthcare environment, the ability to adjust manufacturing output has become increasingly important. Drug shortages continue to affect hospitals, clinics and pharmacies across the United States, particularly for sterile generic medications that healthcare providers rely on every day. When supply disruptions occur, care teams are often forced to seek alternatives, adjust treatment plans or delay care while replacement products are sourced.
The impact of drug shortages is ultimately felt by patients. Ensuring a stable supply of essential medications requires manufacturers that can respond when demand changes.
That responsiveness must occur without compromising the rigorous standards that protect patient safety. Increasing output for a critical medication requires careful coordination across manufacturing, quality and supply chain teams, all while maintaining full compliance with cGMP requirements.
Flexibility Built on Discipline
In pharmaceutical manufacturing, flexibility is only valuable when it is supported by operational discipline. Operational flexibility helps ensure that critical medications remain available when healthcare providers and patients need them most.
By combining advanced manufacturing technology, rigorous quality oversight, and thoughtful operational planning, Ritedose can respond to changing healthcare needs while ensuring that every medication produced meets the standards patients and healthcare providers expect.
Ultimately, our goal remains constant, to ensure that the drugs patients rely on are available when they need them — without compromising quality, safety or trust.
